Return to homepagePandemic Pact

SERODIAGNOSIS. Development of serological tests for the detection of anti-SARS-CoV2 IgG antibodies (Covid 19): application in the diagnosis of infection and in seroepidemiological studies

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $0

  • Funder

    University of São Paulo

  • Principal Investigator

    Maria Cassia and Tania and Thelma Suely Regina and Ester Ester Mendes-Correa and Tozetto-Mendoza and Okay and Sabino

  • Research Location

    Brazil

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

This project aims to develop serological tests capable of testing a large number of patient samples simultaneously, with high sensitivity and specificity and at low cost. The experience of our group in the development of similar serological tests allows us to estimate that in a short period of time, around 3 months, it would be possible to develop the proposed tests. These new tools would enable data on the seroprevalence of SARS-CoV2 infection in the population, which is fundamental for dealing with new epidemic outbreaks caused by it, as recently observed in China, after a period of absence of identification of new cases. Furthermore, these data would be important for the implementation of specific strategies, such as vaccine development.